DONALD Trump's B-2 bomber strike force is massing on the British island of Diego Garcia and is now aimed at Iran. The Ayatollah is running out of time as he faces a deadline slapped on him by the ...

Danish pharmaceutical company Novo Nordisk — best known for its blockbuster weight-loss drugs Ozempic and Wegovy — has signed a $2 billion deal to acquire the global rights to an experimental ...

The Shiba Inu (SHIB) burn rate skyrocketed around 57,069.02% over the last 24 hours, with more than 1 billion SHIB permanently removed from circulation in a single transaction, as per Shibburn ...

Merck (NYSE:MRK) has reached a licensing agreement worth nearly $2B with the Chinese drugmaker Jiangsu Hengrui Pharmaceuticals to jointly develop and commercialize an experimental heart disease ...

The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as rep ...

The Federal Government has commenced the construction of Phase 2B of the access road to the Second Niger Bridge, marking a significant step in enhancing transportation infrastructure and regional ...

Merck joins a growing list of companies targeting lipoprotein(a), high levels of which are associated with an elevated risk of adverse cardiovascular outcomes. Merck is fronting $200 million to ...

Novo Nordisk has signed an exclusive global licensing deal worth up to $2 billion for UBT251, a weight-loss drug developed by China-based The United Laboratories International Holdings Limited.